RENNES, FRANCE, 2019-Apr-08 — /EPR Network/ — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions in nonalcoholic steatohepatitis [read full press release…]
Albany, USA, 2018-Feb-08 — /EPR Network/ —New research report offers a comprehensive analysis of the “Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) [read full press release…]
Albany, USA, 2018-Feb-06 — /EPR Network/ —New research report offers a comprehensive analysis of the “Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) [read full press release…]
